Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2018

01-06-2018 | Preclinical study

Lymph drainage of the upper limb and mammary region to the axilla: anatomical study in stillborns

Authors: Guilherme de Arruda Cuadrado, Mauro Figueiredo Carvalho de Andrade, Flávia Emi Akamatsu, Alfredo Luiz Jacomo

Published in: Breast Cancer Research and Treatment | Issue 2/2018

Login to get access

Abstract

Purpose

We studied the lymphatic drainage of the upper limb and mammary region directing to the axilla to investigate whether independent pathways can be observed or whether anastomoses and shared drainage occur between them. This analysis aimed to assess the safety of axillary reverse mapping (ARM) in breast cancer treatment and to understand the development of lymphedema after sentinel lymph node biopsy (SLNB) alone.

Methods

Seven unfixed stillborn fetuses were injected with a modified Gerota mass in the peri-areolar area, palm and dorsum of the hands, formalin fixed, and then submerged in 10% hydrogen peroxide solution. Microsurgical dissection was then performed on the subcutaneous cellular tissue of the upper limb, axillary region, and anterior thorax to expose the lymphatic vessels and lymph nodes.

Results

The dye injected into the upper limb reached either the lateral axillary group, known to be exclusively responsible for upper limb drainage, or the anterior group, which is typically related to breast drainage. There was great proximity among the pathways and lymph nodes. Communicating lymphatic vessels among these groups of lymph nodes were also found in all studied cases.

Discussion

Lymphedema remains a challenging morbidity in breast cancer treatment. ARM and SLNB aim to avoid unnecessary damage to the lymphatic drainage of the upper limb. However, our anatomical study suggests that ARM may have potential oncological risks because preserved lymph nodes may harbor malignant cells due their proximity, overlapping drainage pathways, and connecting lymph vessels among lymph nodes.

Literature
  1. Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase no. 11. International Agency for Research on Cancer, Lyon
  2. Yue T, Zhuang D, Zhou P et al (2015) A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer 15(4):301–306View ArticlePubMed
  3. Noguchi M, Miura S, Morioka E et al (2015) Is axillary reverse mapping feasible in breast cancer patients? Eur J Surg Oncol 41:442–449View ArticlePubMed
  4. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394–401View ArticlePubMedPubMed Central
  5. Boneti C, Korourian S, Diaz Z et al (2009) Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg 198:482–487View ArticlePubMed
  6. Tausch C, Baege A, Dietrich D et al (2013) Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol 39:880–886View ArticlePubMed
  7. Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W (2015) Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review. Arch Phys Med Rehabil 96:1131–1139View ArticlePubMed
  8. Pavlista D, Eliska O (2012) Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla e a lesson from the past e contribution to the concept of axillary reverse mapping. Eur J Surg Oncol 38:390–394View ArticlePubMed
  9. Suami H, Pan W, Mann B, Taylor I (2007) The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 15(3):863–871View ArticlePubMedPubMed Central
  10. Schunemann E Jr, Dória MT, Silvestre JBCH, Gasperin P Jr, Cavalcanti TCS, Budel VM (2014) Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol 21:2197–2202View ArticlePubMedPubMed Central
  11. Deng H, Chen L, Jia W et al (2011) Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol 137:1869–1874View ArticlePubMed
  12. Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg S (2014) Axillary reverse mapping: 5 year experience. Surgery 156(5):1261–1268View ArticlePubMedPubMed Central
  13. Pavlista D, Elizka O (2012) Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study. Ann Surg Oncol 19:3410–3415View ArticlePubMed
  14. Gobardhan PD, Wijsman JH, van Dalen Th et al (2012) ARM: axillary reverse mapping—The need for selection of patients. Eur J Surg Oncol 38:657–661View ArticlePubMed
  15. Ikeda K, Ogawa Y, Kajino C et al (2014) The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients. Eur J Surg Oncol 40:818–823View ArticlePubMed
  16. Ponzone R, Mininanni P, Cassina E, Sismondi P (2007) Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol 15(1):390–391View ArticlePubMed
  17. Gerota D (1896) Zur technik der lymphgefassinjektion. eine neue injektionsmasse fuer lymphgefasse—polychrome injektion. Anat Anz 12:216–224
  18. Sappey C (1874) Anatomie, physiologie, pathologie des vaisseaux lymphatiques consideres chez l’homme at les vertebres. A. Delahaye and E. Lecrosnier, Paris
  19. Clough KB, Nasr R, Nos C, Vieira M, Inguenault C, Poulet B (2010) New anatomical classification of the axilla with implications for sentinel node biopsy. Br J Surg 97:1659–1665View ArticlePubMed
  20. Lee MC, Eatrides JM, Chau A (2011) Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers. Ann Surg Oncol 18:72–77View ArticlePubMed
  21. Lehman CD, DeMartini W, Anderson BO, Edge SB (2009) Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Cancer Netw 7:193–201View Article
  22. Assing MA, Patel BK, Karamsadkar N, Weinfurtner J, Usmani O, Kiluk JV, Drukteinis JS (2017) A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer. Breast J 23(6):1–9View Article
  23. Sui WF, Chen X, Peng ZK, Ye J, Wu JT (2016) The diagnosis of metastatic axillary lymph nodes of breast cancer by diffusion weighted imaging: a meta-analysis and systematic review. World J Surg Oncol 14:155View ArticlePubMedPubMed Central
  24. Beek MA, Tetteroo E, Luiten EJT, Gobardhan PD, Rutten HJT, Heijns JB, Voogd AC, Klompenhouwer EG (2016) Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy. EJSO 42:672–678View ArticlePubMed
  25. Han C, Yang B, Zuo W-S, Zheng G, Yang L, Zheng M-Z (2016) The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies. PLoS ONE 11(2):e0150285View ArticlePubMedPubMed Central
  26. Cuadrado GA, Andrade MFC, Akamatsu FE, Jacomo AL (2016) Anatomy of the lymphatic drainage of the upper limb and breast and its role in lymphedema prevention after breast cancer treatment. Int J Morphol 34(3):1117–1122View Article
Metadata
Title
Lymph drainage of the upper limb and mammary region to the axilla: anatomical study in stillborns
Authors
Guilherme de Arruda Cuadrado
Mauro Figueiredo Carvalho de Andrade
Flávia Emi Akamatsu
Alfredo Luiz Jacomo
Publication date
01-06-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4686-1

Other articles of this Issue 2/2018

Breast Cancer Research and Treatment 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine